Ooft"When the company stepped up to the fourth dose, they quickly ran into problems as grade 3 and 4 SAEs were observed in patients who received the higher dose of 0.13 mg/kg. This led the trial to drop back down to the third dose level.However, this de-escalation has failed to tame the safety problems as the most recent patient given a dose of 0.08 mg/kg experienced respiratory failure and cardiac arrest, possibly related to MGTA-117, which led to death."
Thankful we have a good understanding Zantrenes safety profile already
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-973
-
- There are more pages in this discussion • 840 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M |
Open | High | Low | Value | Volume |
$1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17175 | $1.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.77 | 6060 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 1.700 |
2 | 2998 | 1.670 |
1 | 5000 | 1.665 |
3 | 3736 | 1.625 |
1 | 5000 | 1.615 |
Price($) | Vol. | No. |
---|---|---|
1.770 | 6060 | 1 |
1.820 | 9999 | 1 |
1.830 | 15000 | 1 |
1.840 | 1499 | 1 |
1.850 | 2500 | 2 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |